What part of chemotaxis in breast cancer has not been studied yet?
Best insight from top research papers
Chemotaxis in breast cancer has been extensively studied, but there are still some aspects that have not been fully investigated. One area that has not been fully understood is the signaling mechanisms underlying chemotaxis in breast cancer cells . While the role of chemokines and their receptors, such as CXCR4 and CXCL12, in promoting cell migration has been established, the specific signaling pathways involved in this process are not completely known . Additionally, the molecular mechanisms of chemoresistance and metastasis in breast cancer cells are still not fully elucidated . Understanding these mechanisms is crucial for developing effective treatment strategies for breast cancer. Further research is needed to explore these areas and uncover the complete picture of chemotaxis in breast cancer.
Answers from top 4 papers
More filters
| Papers (4) | Insight |
|---|---|
| The specific part of chemotaxis in breast cancer that has not been studied yet is not mentioned in the provided information. | |
34 Citations | The signaling mechanisms involving prolonged Akt activation in breast cancer cell chemotaxis have not been extensively studied. |
19 Citations | The mechanisms of breast cancer chemoresistance and metastasis have not been fully investigated. |
13 Citations | The effects of the absolute concentration of EGF on chemotaxis of breast cancer cells have not been systematically studied. |
Related Questions
How to use chemotaxis to design a tissue engineering solution?5 answersTo design a tissue engineering solution utilizing chemotaxis, one can incorporate chemoattractants into scaffolds to enhance cell seeding. By releasing chemoattractants at a controlled rate within the scaffold, cells can be guided to migrate along concentration gradients, improving distribution. Additionally, the use of chemotactic factors like vascular endothelial growth factor (VEGF) can attract mesenchymal stem cells, promoting angiogenesis and tissue regeneration. Furthermore, microfluidic chips can be employed to study cellular responses to chemotactic cues in a controlled environment, aiding in understanding cellular locomotion and growth within tissue-engineered constructs. By considering the interplay of adhesion, chemotaxis, and controlled release of chemoattractants, a comprehensive approach can be developed to leverage chemotaxis for effective tissue engineering solutions.
What are the mechanisms of chemotaxis in Proteus mirabilis?4 answersChemotaxis mechanisms in Proteus mirabilis have been studied to determine their involvement in swarming. Nonchemotactic mutants of P. mirabilis were found to swarm on a medium containing agar, indicating that chemotaxis is not necessary for swarming. In addition, no clear evidence of negative chemotaxis was observed in wild-type P. mirabilis, even when multiple assays and chemicals were tested. These findings suggest that chemotaxis is not involved in the swarming behavior of P. mirabilis.
Which chemotaxis factors are involved in leukocyte interaction with inflamed endothelial cells?4 answersLeukocyte interaction with inflamed endothelial cells involves several chemotactic factors. The selectins, expressed by both leukocytes and endothelial cells, facilitate the initial loose adherence and rolling of leukocytes along the endothelium. Chemotactic factors such as C5a and IL-8 attract neutrophils to sites of inflammation, triggering their migration towards the inflamed endothelium. The β2 integrins expressed by leukocytes are activated by soluble inflammatory factors and engage counter ligands, such as intercellular adhesion molecules (ICAMs), expressed by endothelial cells, leading to tight adhesion. This tight adhesion permits transendothelial migration of leukocytes towards the subendothelial matrix in proximity to pathogenic bacteria. Therefore, the selectins, chemotactic factors (C5a and IL-8), and β2 integrins play crucial roles in leukocyte interaction with inflamed endothelial cells.
What does results in when fish oil and chemotherapeutic drugs reacts in breast cancer?5 answersFish oil supplementation in conjunction with chemotherapeutic drugs has shown positive effects in breast cancer. Omega-3 polyunsaturated fatty acids (PUFAs) found in fish oil have been found to increase the effectiveness of cancer chemotherapeutic drugs without increasing their toxicity to the host mouse. Omega-3 fatty acids have been reported to have several anti-tumor effects, including increased lipid peroxidation, disturbed tumor receptor signal pathways, lower levels of pro-inflammatory cytokines, promotion of apoptosis, immune modulation, and changes in hormonal metabolism. Polyphenol-rich extract from olive mill wastewater, combined with chemotherapy, has shown potential cardiovascular protection in breast cancer patients while increasing the effects of chemotherapy. In patients with gastric cancer, fish oil intake during chemotherapy has been found to reduce side effects such as nausea and abdominal cramps. Fish oil supplementation during chemotherapy in gastrointestinal cancer patients has also been shown to prevent loss of muscle mass and improve quality of life.
What part of chemotaxis in cancer has not been studied yet?5 answersChemotaxis in cancer has been extensively studied, but there are still some aspects that remain less characterized. One area that has not been fully explored is the role of exosome-type extracellular vesicles in cancer cell chemotaxis. While chemotaxis of immune cells and stromal cells in the tumor microenvironment has been well studied, the specific mechanisms and molecular pathways regulating chemotaxis in cancer cells are not fully understood. Additionally, the downstream events and signaling pathways involved in cancer cell chemotaxis, such as the role of Cdc42 and other GTPases, are still being investigated. Furthermore, the signaling mechanisms underlying chemotaxis in specific types of cancer cells, such as breast cancer cells, are not completely elucidated. Overall, further research is needed to fully understand the complexities of chemotaxis in cancer and its potential implications for cancer progression and metastasis.
What are the mechanisms involved in mechanosensing on breast cancer cell migration?4 answersMechanosensing in breast cancer cell migration involves several mechanisms. The remodeling and stiffening of the extracellular matrix (ECM) play a role in disease progression. Autophagy-inducing serine/threonine kinases ULK1 and ULK2 inhibit the assembly of actin stress fibers and focal adhesions, leading to impaired cell contraction and migration. ULK1/2 phosphorylate PXN, a key component of the mechanotransducing machinery, weakening its interactions and impairing focal adhesion assembly. FAK/Src and ULK1/2 have opposing functions in mechanotransduction, competing for phosphorylation of PXN. Increases in stiffness, interstitial fluid pressure, and solid stress promote malignant phenotypes in breast cancer cells. EVL, a member of the Ena/VASP family, polymerizes actin at focal adhesions, promoting mechanosensing and durotaxis. Changes in membrane tension result in heterogeneous expression of adhesive structures during breast cancer cell migration. These mechanisms collectively regulate mechanosensing and migration in breast cancer cells.